• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase

tetano

Editor, Senior Moderator
Bioorg Med Chem. 2015 Jul 29. pii: S0968-0896(15)00630-6. doi: 10.1016/j.bmc.2015.07.046. [Epub ahead of print]
[h=1]Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.[/h] Fudo S[SUP]1[/SUP], Yamamoto N[SUP]2[/SUP], Nukaga M[SUP]3[/SUP], Odagiri T[SUP]4[/SUP], Tashiro M[SUP]4[/SUP], Neya S[SUP]1[/SUP], Hoshino T[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Seasonal epidemics and occasional pandemics caused by influenza viruses are global threats to humans. Since the efficacy of currently approved drugs is limited by the emerging resistance of the viruses, the development of new antiviral drugs is still demanded. Endonuclease activity, which lies in the influenza polymerase acidic protein N-terminal domain (PA[SUB]N[/SUB]), is a potent target for novel antiviral agents. Here, we report the identification of some novel inhibitors for PA[SUB]N[/SUB] endonuclease activity. The binding mode of one of the inhibitory compounds to PA[SUB]N[/SUB] was investigated in detail by means of X-ray crystal structure analysis and molecular dynamics (MD) simulation. It was observed in the crystal structure that three molecules of the same kind of inhibitor were bound to one PA[SUB]N[/SUB]. One of the three molecules is located at the active site and makes a chelation to metal ions. Another molecule is positioned at the space adjacent to the metal-chelated site. The other molecule is located at a site slightly apart from the metal-chelated site, causing a conformational change of Arg124. The last binding site was not observed in previous crystallographic studies. Hence, the stability of inhibitor binding was examined by performing 100-ns MD simulation. During the MD simulation, the three inhibitor molecules fluctuated at the respective binding sites at different amplitudes, while all of the molecules maintained interactions with the protein. Molecular mechanics/generalized Born surface area (MM/GBSA) analysis suggested that the molecule in the last binding site has a higher affinity than the others. Structural information obtained in this study will provide a hint for designing and developing novel potent agents against influenza viruses.
Copyright ? 2015 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Crystal structure analysis; Endonuclease activity; Influenza virus; Inhibitor; Molecular dynamics simulation; Polymerase acidic protein

PMID: 26252962 [PubMed - as supplied by publisher]
 
Back
Top Bottom